Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 33.87M P/E - EPS this Y - Ern Qtrly Grth -
Income 5.08M Forward P/E - EPS next Y - 50D Avg Chg -11.00%
Sales 23.36M PEG - EPS past 5Y - 200D Avg Chg -16.00%
Dividend N/A Price/Book 1.45 EPS next 5Y - 52W High Chg -43.00%
Recommedations - Quick Ratio 4.67 Shares Outstanding 136.70M 52W Low Chg 8.00%
Insider Own 14.55% ROA 3.82% Shares Float 115.55M Beta 0.37
Inst Own 0.43% ROE 20.04% Shares Shorted/Prior -/- Price 0.25
Gross Margin 57.21% Profit Margin 21.73% Avg. Volume 8,522 Target Price -
Oper. Margin 3.27% Earnings Date Dec 19 Volume 7,250 Change 0.00%
About MICROBIX BIOSYSTEMS

Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.